When one reads into all the directions that the 3 drugs IPIX has and that all the trials have shown promising success every time. One has to marvel at the future potential here. What throws me is the low PPS and that more independent stock researchers have not done articles on this one. Many articles and deals have been made on other development stage drugs in PHASE II, IPIX is being overlooked IMO. PHASE III trial studies not that far away now. And what comes after PHASE III ??? HMMMM